Sedana Medical AB (publ)
STO:SEDANA

Watchlist Manager
Sedana Medical AB (publ) Logo
Sedana Medical AB (publ)
STO:SEDANA
Watchlist
Price: 11.96 SEK -2.45% Market Closed
Market Cap: 1.2B SEK
Have any thoughts about
Sedana Medical AB (publ)?
Write Note

Sedana Medical AB (publ)
Cash from Investing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Sedana Medical AB (publ)
Cash from Investing Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Investing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Sedana Medical AB (publ)
STO:SEDANA
Cash from Investing Activities
-kr31.4m
CAGR 3-Years
34%
CAGR 5-Years
7%
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Cash from Investing Activities
-kr1.9B
CAGR 3-Years
-46%
CAGR 5-Years
-23%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Cash from Investing Activities
-kr47.2m
CAGR 3-Years
74%
CAGR 5-Years
26%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Cash from Investing Activities
-kr74.5m
CAGR 3-Years
1%
CAGR 5-Years
-30%
CAGR 10-Years
-17%
Getinge AB
STO:GETI B
Cash from Investing Activities
-kr6.5B
CAGR 3-Years
-49%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Cash from Investing Activities
-kr637m
CAGR 3-Years
13%
CAGR 5-Years
2%
CAGR 10-Years
N/A
No Stocks Found

Sedana Medical AB (publ)
Glance View

Market Cap
1.2B SEK
Industry
Health Care

Sedana Medical AB is a medical technology company, which engages in the development, manufacture, and sale of medical devices and drug development for future projects around AnaConDa. The company is headquartered in Danderyd, Stockholm. The company went IPO on 2017-06-21. The company develops, markets and sales medical devices and conducts drug development for future projects around AnaConDa technology. The AnaConDa technology delivery enables of volatile anaesthetics to invasively ventilated patients. The products portfolio comprises disposable medical devices AnaConDa for administration of volatile anaesthetics, AnaConDa syringes, FlurAbsorb charcoal filters for removing halogenated hydrocarbon anaesthetic gases, different lines and connectors which can be used to connect the FlurAbsorb filter, adaptors, among others. The Company’s main shareholders are board members, Linc AB and Magiola Consulting AB.

SEDANA Intrinsic Value
7.55 SEK
Overvaluation 37%
Intrinsic Value
Price

See Also

What is Sedana Medical AB (publ)'s Cash from Investing Activities?
Cash from Investing Activities
-31.4m SEK

Based on the financial report for Sep 30, 2024, Sedana Medical AB (publ)'s Cash from Investing Activities amounts to -31.4m SEK.

What is Sedana Medical AB (publ)'s Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 5Y
7%

Over the last year, the Cash from Investing Activities growth was 90%. The average annual Cash from Investing Activities growth rates for Sedana Medical AB (publ) have been 34% over the past three years , 7% over the past five years .

Back to Top